Trochanter Fixation Nail Advanced (TFNA) Weight Bearing
NCT ID: NCT03160508
Last Updated: 2021-07-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
16 participants
OBSERVATIONAL
2017-10-20
2020-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Focused Registry on the Titanium Trochanter Fixation Nail Advanced (TFNAdvanced™)
NCT02305121
Proximal Femoral Nail Antirotation (PFNA) Versus PFNA Augmentation
NCT01473082
Intramedullary Devices for the Treatment of Unstable Pertrochanteric Fractures
NCT02074969
DePuy Trochanteric (ATN) Nailing Clinical Outcomes Trial
NCT00546429
Static Helical Screw Locking of Pertrochanteric Femur Fractures Using the TFN-A
NCT04851509
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In addition to weight bearing measurements, perceived pain (numeric rating scale), mobility (Parker Mobility Score and Time Up and Go Test) will be assessed at 6 and 12 weeks after surgical treatment and in conjunction with the standard (routine) of care follow up schedule. In order to investigate the relationship between these variables and the weight bearing measurements, patients or their care takers or assisting family members will be asked to document the daily use of the insole in a diary.
Finally, over the course of the study, anticipated adverse events (AE) that may affect the healing process will be collected. Special attention will be given to implant- or bone-related AEs. Images from patients with implant- or bone related AEs will be collected as per standard of care
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fracture fixation with the TFNA
Fracture fixation with the TFNA
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients treated with the TFNA; i.e. according to the technique guide and the indications for use, patients who presented any of the following conditions:
* Stable or unstable pertrochanteric fractures
* Intertrochanteric fractures
* Basal neck fractures
* Combinations of pertrochanteric, intertrochanteric, and basal neck fractures
* Patients who were able to walk before the fracture and are prescribed full weight bearing as tolerated post-surgery
* Ability to understand the content of the patient information / informed consent form
* Willingness and ability to participate in the study according to the clinical investigation plan
* Signed and dated ethical committee approved written informed consent according to the local regulations
Exclusion Criteria
* Any condition, which impairs weight bearing (e.g. additional acute fracture on the ipsilateral and/or contralateral side, pain)
* Patients, who due to their condition, are in opinion of the Prinicipal Investigator (PI) unable to complete a reliable assessment
* Pregnancy or women planning to conceive within the study period
* Participation in any other medical device or medicinal product registry within the previous month that could, in opinion of the PI, influence the results of the present study
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AO Innovation Translation Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Blauth, Prof.
Role: PRINCIPAL_INVESTIGATOR
Medical University Innsbruck
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University Innsbruck
Innsbruck, , Austria
Kantonsspital Baselland
Binningen, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TFNA weight bearing
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.